Find key information for shareholders in 4D pharma plc
4D pharma plc
9 Bond Court
Leeds LS1 2JZ
For all enquiries please contact firstname.lastname@example.org
There are 131,467,935 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 131,467,935.
Please view the table below for the interests of major shareholders of 3% or more which have been notified to the Company.
Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 25.22%. 1
There are no restrictions as to the transfer of ordinary shares.
|Ordinary shares held||%|
|4D pharma plc Directors and related holdings||16,707,731||12.70%|
|Hargreaves Lansdown Asset Management||16,692,909||12.70%|
|South Ocean Capital Management LLC and connected parties||16,452,880||12.51%|
|Merck & Co.||7,661,000||5.83%|
|Interactive Investor Trading||7,153,800||5.44%|
|Mr David R Norwood||6,000,000||4.56%|
|Halifax Share Dealing||4,641,992||3.53%|
This information was last updated as of 12 November 2020.
1 Shares not in public hands are defined as those held by 4D pharma plc Directors and related holdings and substantial shareholders of ≥10%
Meetings and voting
Advisers and registrars
1 Bartholemew Lane
Bryan Garnier & Co. Limited
15 St. Botolph Street
London EC3A 7BB
RSM UK Audit LLP
3 Hardman Street
Manchester M3 3HF
Link Asset Services
34 Beckenham Road
Kent BR3 4TU